GP probably won't be keen
But that autonomy has to be balanced against responsible prescribing, honest risk disclosure, and a healthcare system that isnt overwhelmed by cosmetic demand crowding out patients with genuine medical need a tension the off-label ethics literature explicitly frames as a policy challenge, not just an individual choice (Journal of Population Therapeutics and Clinical Pharmacology, 2023)
Y., Nishida, M., Kumagai, Y., Alam, M
It is called polypharmacy syndrome
342 The tri-agonist lowered body weight in diet-induced obese mice by 26.6% after 20 days of treatment, whereas the GLP-1R/GIPR coagonist lowered body weight by 15.7%, and it was found that the action of the tri-agonist occurred in a dose-dependent manner
For enhanced results, regularly exfoliate the eye area using THE PEELUMINATOR